Evaluation of the efficiency of perioperative chemotherapy in the complex treatment of gastric cancer
Authors:
Open Access
- 19 July 2021
- journal article
- research article
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 20 (2) , 17-22
Abstract
Introduction.Of greatest interest in the complex treatment of gastric cancer is the assessment of the effect of perioperative chemotherapy on the immediate and long-term results of treatment. Including, the possibility of studying the effectiveness of chemotherapy, its effect on the resectability of the tumor process, determining the possibility of an indirect correlation for intra — and postoperative complications.The aim of the studyis to study the effectiveness of perioperative chemotherapy in the treatment of gastric cancer and its direct effect on the results of surgical treatment.Methods.At the base Chelyabinsk Center of Oncology and Nuclear Medicine, studies are being conducted to assess the effectiveness and tolerability of perioperative chemotherapy in the complex treatment of gastric cancer. Based on the inclusion criteria, 80 patients were selected with a diagnosis of gastric cancer T2-3N0-2M0. The first stage of all patients underwent diagnostic laparoscopy with negative peritoneal washings. The male to female ratio was 51% and 49%, respectively. The average age of the patients was 61 years. By morphological structure, gastric adenocarcinoma prevailed — 85%, cricoid cell carcinoma was 9%, adenocarcinoma with a cricoid cell component — 6%. According to the T category, the patients were distributed as follows: cT2 — 5%; sT3 — 59%; cT4 — 36%. In category N, patients of category N1 prevailed — 59%; patients with cN0 and cN1 were represented in approximately equal proportions, 14% and 19%, respectively. Patients with stage II accounted for 33%, with stage III — 67%. The main combination of drugs was FLOT (87%), FolFox (3%), XELOX (5%), PF (5%) were also used.Results. The data obtained clearly demonstrate the good tolerability of the performed preoperative chemotherapy, the absence of significant adverse reactions. Drug therapy did not affect the planned timing of the surgical stage of treatment. Also, no effect of chemotherapy on postoperative complications was noted. R0 resection was performed in 100% of cases. In 49% of cases, stage reduction was performed. Significant medical grade III — IV pathomorphosis was obtained in 26% of cases. Discussion.Interpretation of therapeutic tumor pathomorphosis for evaluating the effectiveness and planning of adjuvant therapy currently requires further study and evaluation.Conclusion.Perioperative chemotherapy is not accompanied by adverse reactions affecting the timing and outcome of treatment. The obtained positive clinical effect according to examination data, intraoperative visual assessment suggests an improvement in overall survival and a decrease in one-year mortality in the complex treatment of gastric cancer.Keywords
This publication has 18 references indexed in Scilit:
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trialThe Lancet Oncology, 2014
- Staging Laparoscopy in the Management of Gastric Cancer: A Population-Based AnalysisJournal of the American College of Surgeons, 2011
- A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancerGastric Cancer, 2011
- Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III TrialJournal of Clinical Oncology, 2011
- Impact of the Extent of Surgery and Postoperative Chemoradiotherapy on Recurrence Patterns in Gastric CancerJournal of Clinical Oncology, 2010
- Neoadjuvant chemotherapy for advanced gastric cancer: A meta-analysisWorld Journal of Gastroenterology, 2010
- Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate DataJournal of Clinical Oncology, 2006
- Does Resection Line Involvement Affect Prognosis in Early Gastric Cancer Patients? An Italian Multicentric StudyWorld Journal of Surgery, 2006
- Risk factors for pancreas-related abscess after total gastrectomyGastric Cancer, 2005
- Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal JunctionNew England Journal of Medicine, 2001